<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04167436</url>
  </required_header>
  <id_info>
    <org_study_id>REG-040-2017</org_study_id>
    <nct_id>NCT04167436</nct_id>
  </id_info>
  <brief_title>Fit for Surgery. Multimodal Prehabilitation in Colorectal Cancer Patients</brief_title>
  <official_title>Fit for Surgery. Clinical Randomized Trial of Multimodal Prehabilitation Strategy in Patients With Colorectal Cancer.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial of multimodal prehabilitation in vulnerable patients with colon or
      rectal cancer prior to surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fit for surgery is a randomized clinical trial of multimodal prehabilitation prior to colon
      or rectal cancer surgery. Participants will either receive

      The study is a part of the PREHAB study which is performed in collaboration with
      international centers.

      The full protocol are published BMC Cancer. 2019 Jan 22;19(1):98. doi:
      10.1186/s12885-018-5232-6.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Clinical Trial with an intervention arm and a standard of care arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Due to the nature of the interventions neither participant, care provider or investigator is blinded. Outcome assessor of primary outcomes are blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of Recovery 15</measure>
    <time_frame>3 days after surgery</time_frame>
    <description>Difference in postoperative recovery between baseline and within 3 days after surgery. The cumulative score ranges from 0-150, with a higher value indicating a better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in physical fitness prior to surgery</measure>
    <time_frame>Baseline, prior to surgery and 30 days after surgery</time_frame>
    <description>Changes in VO2 max between baseline and prior to surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Complications measured by the comprehensive complication index. The score ranges from 0-100 with with a higher value indicating a worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in immunological function</measure>
    <time_frame>Blood work taken at baseline, prior to surgery, three days after surgery and four weeks after surgery. Tumor from resectionspecimen</time_frame>
    <description>Changes in immunological function measured by nanostring in blood and tumor (in the invasive front)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease specific quality of life - EORTC c30</measure>
    <time_frame>the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery</time_frame>
    <description>European Organisation for Research and Treatment of Cancer Questionaire c 30 (EORTC c30). The EORTC c30 contains 6 domains which will each be assessed for mean changes in their cumulative score. The domains are physical function, role function, emotional function, pain, fatigue and global health. A higher value indicating a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease specfic quality of life - EORTC c29</measure>
    <time_frame>the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery</time_frame>
    <description>European Organisation for Research and Treatment of Cancer Questionaire c 29 (EORTC). The questionnaire contains 29 items, with a 4 point Likert scale for symptoms and 7 point Likert scale for quality of life and global health. For the 4 point Likert scale the higher the score the worse the outcome. For the 7 point likert scale higher values indicating a better outcome. Analysis will be performed for changes in individual symptoms and cumulative aggregation of scores will not be performed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall quality of life - SF-36</measure>
    <time_frame>the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery</time_frame>
    <description>Short Form 36 question (SF-36) health questionnaire. The questionnaire contains eight domains: physical functioning, pain, limitations due to physical health problems, limitations due to personal or emotional problems, emotional well-being, social functioning, fatigue, and general health perceptions. Scores for each domain range from 0 to 100 and the analysis will be performed as mean difference between baseline and the following time frame. A higher value indicating a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological health - Depression - PHQ-9</measure>
    <time_frame>the day prior to surgery,30 days after surgery, 60 days after surgery and one year after surgery</time_frame>
    <description>Patient Health Questionnaire 9 (PHQ-9) Depression test. The PHQ-9 have a maximum of 27 points and a minimum of 0. The outcome is point change between baseline and following time frame. A higher value indicating a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological health - General anxiety - GAD-7</measure>
    <time_frame>the day prior to surgery, 30 days after surgery, 60 days after surgery and one year after surgery</time_frame>
    <description>General Anxiety Disorder 7-item (GAD-7). The questionnaire have a maximum of 21 points and a minium of 0. The outcome is the point change between baselin and the following time frame. A higher value indicating a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function (6-MWT)</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery</time_frame>
    <description>6-Minutes walk test. Measures how far the participant can walk in 6 minutes measured in meters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function (STS)</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery.</time_frame>
    <description>Sit-to-stand test. Test of how many times the patient can rise from a chair in 30 seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function (Stair climb test)</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery</time_frame>
    <description>Stair climb test will be measured as the number of steps (17 mc in height) the paitent can rise in 30 secounds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function (Leg extension test)</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery</time_frame>
    <description>Leg extension test will be measured by fixed dynaometer in newtons three times on each leg and the maximum for each leg used for analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function (Hand grip strength)</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery</time_frame>
    <description>Hand grip strength measured by hand-held dynanometer in kilograms. Measured 3 times on each hand and will use the maximum obtained.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>The day prior to surgery, 30 days after surgery, and 60 days after surgery</time_frame>
    <description>Increase/decrease in total body weight in percent.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Remission and cancer free survival</measure>
    <time_frame>5 years</time_frame>
    <description>Remission and cancer free survival</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Colon Cancer</condition>
  <condition>Rectal Cancer</condition>
  <condition>Frailty</condition>
  <arm_group>
    <arm_group_label>Prehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive multi-modal prehabilitation with exercise three times weekly, protein supplements, vitamin supplements, dietitian consultation and medical optimization prior to surgery. A minimum of four weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Receives standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Prehabilitation</intervention_name>
    <description>A minimum of four weeks of prehabilitation with exercise three times a week, protein and vitamin supplements, dietitian consultation and medical optimization prior to surgery.</description>
    <arm_group_label>Prehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Undergoing elective colorectal cancer surgery

          -  WHO performance status I and II

          -  Signed consent

        Exclusion Criteria:

          -  Known metastatic disease

          -  Unable to perform baseline test or basic training e.g. paralytic or completely
             immobilized patients, orthopedic impairments.

          -  ASA 4 or 5 (American Society of Anesthesiologist Classification)

          -  Neoadjuvant chemo- or radiation therapy

          -  Renal failure III B or higher

          -  Illiteracy or unable to write or understand Danish

          -  Cognitive disabilities, which affects adherence e.g. severe dementia (MMSE score ≤17).

          -  Withdrawal of consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zealand University Hospital</name>
      <address>
        <city>Køge</city>
        <state>Danmark</state>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rasmus D Bojesen, MD</last_name>
      <phone>26193789</phone>
      <email>rasmus.bojesen@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Slagelse Hospital</name>
      <address>
        <city>Slagelse</city>
        <state>Danmark</state>
        <zip>4200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rasmus D Bojesen, MD</last_name>
      <phone>26193789</phone>
      <email>rasmus.bojesen@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 11, 2019</study_first_submitted>
  <study_first_submitted_qc>November 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2019</study_first_posted>
  <last_update_submitted>November 19, 2019</last_update_submitted>
  <last_update_submitted_qc>November 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prehabilitation</keyword>
  <keyword>Colon cancer</keyword>
  <keyword>WHO performance status</keyword>
  <keyword>Rectal cancer</keyword>
  <keyword>Exercise</keyword>
  <keyword>Nutritional supplement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
    <mesh_term>Colonic Neoplasms</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

